ADD ANI AS A TRUSTED SOURCE
googleads
Menu

      
      Novo Nordisk launches world's first once-weekly insulin in India

Novo Nordisk launches world's first once-weekly insulin in India

In the ONWARDS-1 clinical programme, Awiqli; demonstrated superior HbA1c reduction and increased Time in Range...


      
      Elevate Now's Data Suggests Metabolic Reversal

Elevate Now's Data Suggests Metabolic Reversal

New Delhi [India], July 2: For decades, obesity treatment has been measured using a single metric: weight loss....

      
      True Hope Foundation extends RS. 1.21 Crore support

True Hope Foundation extends RS. 1.21 Crore support

In a significant step toward supporting children affected by rare diseases, Jodhpur-based True Hope Foundation...


      
      Pennant Technologies Achieves SOC 2® Type 2 Compliance

Pennant Technologies Achieves SOC 2® Type 2 Compliance

Hyderabad (Telangana) [India], June 8: Pennant Technologies, an agile and innovative financial technology company,...

      
      How Metabolic Surgery Reverses Multiple Health Problems

How Metabolic Surgery Reverses Multiple Health Problems

New Delhi [India], May 26: In today's medical science, one of the most advanced and effective processes to treat...

      
      Sight preserved in the patient's only seeing eye

Sight preserved in the patient's only seeing eye

Kolkata (West Bengal) [India], May 26: An elderly man in his sixties with multiple health complications, including...

      
      Zydus Launches Semaglutide Injection in an Innovative

Zydus Launches Semaglutide Injection in an Innovative

Ahmedabad (Gujarat) [India], March 21: Zydus Lifesciences Limited (including its subsidiaries, hereafter referred to...

      
      Type 1 diabetes associated with higher risk of dementia

Type 1 diabetes associated with higher risk of dementia

"As advances in medical care have extended the lives of people with type 1 diabetes, it's becoming increasingly...

      
      CliniExperts Supports Completion of AMPLIFY-TIR Diabetes Study

CliniExperts Supports Completion of AMPLIFY-TIR Diabetes Study

New Delhi [India], March 18: We are pleased to announce the successful completion of the AMPLIFY-TIR Study, which...

      
      Disruption In India’s Wellness Market: dLife

Disruption In India’s Wellness Market: dLife

New Delhi [India], March 6: India's chronic lifestyle disease management playbook has traditionally focused on...

      
      Standard diabetes test may mislead diagnosis

Standard diabetes test may mislead diagnosis

Led by Professor Anoop Misra and collaborators, the review questions reliance on HbA1c as a sole diagnostic or...


      
      “There must be judicious use of any medicine and same with Ozempi

“There must be judicious use of any medicine and same with Ozempi

"Bringing Ozempic® to India is a major milestone", said Shrotriya.

Home About Us Our Products Advertise Contact Us Terms & Condition Privacy Policy

Copyright © aninews.in | All Rights Reserved.